Evidence map›Paper›PMID 38097777›Full record

ReviewNature reviews. Immunology2024

Olfactory immunology: the missing piece in airway and CNS defence.

Sebastian A Wellford, E Ashley Moseman

Abstract readReview
In one paragraph

Review in Nature reviews. Immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. SARS-CoV-2 virus infection ofbioRxiv : the preprint server for biology · 2026
    Article
  13. Review
  14. Article
  15. Olfactory immunity: defending the neural-mucosal barrier.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Review
  16. [Research progress on the improvement of olfactory function by different surgical procedures for chronic rhinosinusitis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2026
    Review
  17. The cribriform plate: A dynamic central nervous system-immune hub.The Journal of experimental medicine · 2026
    Review
  18. Review
  19. Olfactory Decline in Elderly at High Altitudes: A Narrative Review.International journal of general medicine · 2026
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sebastian A WellfordDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, USA.ORCID http://orcid.org/0000-0002-2535-6893
E Ashley MosemanDepartment of Integrative Immunobiology, Duke University School of Medicine, Durham, NC, USA. ashley.moseman@duke.edu.ORCID http://orcid.org/0000-0002-6064-6116

Funding

Basic Immunology Training ProgramT32AI052077 · NIAID · DUKE UNIVERSITY · PI KRANGEL, MICHAEL S · 2002 to 2024
$4.2M
Treatment of Primary Amoebic Meningoencephalitis via Modulation of Antibody Effector FunctionsR01NS121067 · NINDS · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2021 to 2025
$2.0M
Infectious Influence: Using fate mapping to determine the impact of viral infection sites on Alzheimer's disease initiationR21AG074324 · NIA · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2021 to 2022
$439k
Defining the molecular and anatomical basis of the blood-olfactory barrier (BOB)R21DC021260 · NIDCD · DUKE UNIVERSITY · PI MOSEMAN, E. ASHLEY · 2023 to 2023
$434k
NIAID NIH HHS T32 AI052077NIA NIH HHS R21 AG074324NIDCD NIH HHS R21 DC021260NINDS NIH HHS R01 NS121067
6 · The paper itself

Abstract

The olfactory mucosa is a component of the nasal airway that mediates the sense of smell. Recent studies point to an important role for the olfactory mucosa as a barrier to both respiratory pathogens and to neuroinvasive pathogens that hijack the olfactory nerve and invade the CNS. In particular, the COVID-19 pandemic has demonstrated that the olfactory mucosa is an integral part of a heterogeneous nasal mucosal barrier critical to upper airway immunity. However, our insufficient knowledge of olfactory mucosal immunity hinders attempts to protect this tissue from infection and other diseases. This Review summarizes the state of olfactory immunology by highlighting the unique immunologically relevant anatomy of the olfactory mucosa, describing what is known of olfactory immune cells, and considering the impact of common infectious diseases and inflammatory disorders at this site. We will offer our perspective on the future of the field and the many unresolved questions pertaining to olfactory immunity.

Indexed as

COVID-19Olfactory MucosaSARS-CoV-2AnimalsCentral Nervous SystemHumansImmunity, MucosalSmell

Identifiers

PMID38097777
PMCPMC11560121

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.